Pratik Shah
Chairman of the BoardDr. Pratik Shah, Ph.D., is an Executive Chairperson at Design Therapeutics, Inc. since December 2017 and serves as its President, Chief Executive Officer and Principal Financial Officer since August 25, 2023. He is a Co-Founder of Design Therapeutics, Inc. Dr. Shah served as the President and Chief Executive Officer at Marlinspike Group, Inc. from July 2015 to October 2020. Dr. Shah serves as the Chairman of the Board at ARS Pharmaceuticals, Inc. since 2018 and serves as its Director since 2016. He was a Partner at Thomas, McNerney & Partners. Dr. Shah joined Thomas, McNerney & Partners on November 8, 2004. He was previously the Chief Executive Officer and President at Auspex Pharmaceuticals, Inc. since October 17, 2013. Dr. Shah Co-Founder at Kalypsys and served as its Chief Business Officer and was responsible for the overall strategy, business development and operations of it and oversaw raising more than 130 million in equity financings and corporate deals. Prior to Kalypsys, Dr. Shah was at McKinsey & Company, where he focused on biotechnology and venture capital, including projects such as the spin-off of a new venture from a leading biotechnology company, development of corporate strategies for informatics and biopharmaceutical companies and due diligence for mergers and acquisitions and venture investing. Prior to joining McKinsey, Dr. Shah was a Co-Founder and Vice President of Operations at NephRx Corporation. He was also involved in helping Arch Venture Partners with their biotechnology seed investments. Dr. Shah served as President and Chief Executive Officer of Design Therapeutics, a position he has held since December 2017. Dr. Shah served as the Chairman at Auspex Pharmaceuticals, Inc. from September 2008 to October 17, 2013 and had been its Director since June 2007. He served as a Director of Cebix Incorporated. Dr. Shah served as the Chairman and Director of Synthorx, Inc. from December 20, 2018 to January 22, 2020 and from October 11, 2018 to January 22, 2020 respectively. He serves as a Director of SG Biofuels, Inc. He served as a Director at CNS Therapeutics, Inc. Dr. Shah served as a Director of Ocera Therapeutics, Inc. since September 2005 until February 18, 2014. He was the Chairman of Altair Therapeutics, Inc. He has entrepreneurial and leadership experience in the biopharma industry. Dr. Shah has authored original research and review papers in the field of molecular biology. Dr. Shah holds a Ph.D. in Biochemistry and Molecular Biology, an M.B.A. in Finance from the University of Chicago and a B.S. in Biological Sciences from the University of California at Irvine between 1988 and 1991.
Positions
- Company NameARS Pharmaceuticals, Inc.Stock CodeSPRYPositionChairman of the BoardColleagues
- JCJustin ChakmaChief Business Officer
- PSPratik ShahChairman of the Board
- DCDonn CasaleCEO, President & Director
- RBRobert BellCo-Founder & Chief Science Officer
- KDKathleen D. ScottChief Financial Officer
- BTBrian T. DorseyChief Operating Officer
- PKPeter KolchinskyIndependent Director
- PMPhillip M. SchneiderIndependent Director
- SISaqib IslamIndependent Director
- Company NameDesign Therapeutics, Inc.Stock CodeDSGNPositionCo-Founder, President, CEO, Principal Financial Officer & Executive Chairperson
